FDA Lifts Urological Restriction for Medafor’s Arista™AH
Arista™AH Absorbable Hemostat is now available for use in urological surgical procedures. The FDA has removed the restriction on this application of Arista™AH from the device indication statement.
FDA OKs Arista™AH for U.S. Operating Rooms
Medafor's Arista™AH Absorbable Surgical Hemostat recently received FDA PMA for surgical markets within the U.S. Arista™AH has been distributed internationally since 2002 and has compiled a remarkable record of surgical successes around the world.
FlexiTip™ Applicator Facilitates Surgical Wound Access
Medafor's new FlexiTip™ applicator for use with Arista™AH aids in the accurate delivery of this safe, simple and effective hemostatic powder to difficult to reach bleeding sites.
Medafor's MPatcH® Device to International Markets
Medafor's MPatcH® vascular closure system is now available to markets in Europe, Africa, the Middle East, Central and South America and Asia-Pacific.
Orlando, Florida
Combined Otolaryngology Spring Meetings
May 1-4, 2008
Geneva, Switzerland
Spineweek
May 26-31, 2008
Chicago, Illinois
112th Annual Meeting and OTO Expo, American Academy of Otolaryngology
September 21-24, 2008